BA
DPLO

BKS Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

BKS Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5,000
Closed -$140K – 248
2016
Q3 		$140K Buy
+5,000
New +$168K 0.06% 191

Other funds holding DPLO

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BKS Advisors's DPLO Position: Q4 2016 in Review

BKS Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2016, closing a stake of 5,000 shares — an estimated $140K sold.

BKS Advisors first reported a position in DPLO in Q3 2016 and held it in 1 quarter. The position peaked at $140K in Q3 2016. 174 funds tracked by Wall St. Rank hold DPLO as of Q4 2016.

  • BKS Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2016 after selling out during the quarter.
  • BKS Advisors sold 5,000 DIPLOMAT PHARMACY, INC. shares in Q4 2016, an estimated $140K.
  • BKS Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2016 and held it in 1 quarter.
  • BKS Advisors's DIPLOMAT PHARMACY, INC. position peaked at $140K in Q3 2016.
  • 174 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2016.

Based on BKS Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.